Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Lucas R. Massoth, MD, Yin P. Hung, MD, PhD, Judith A. Ferry, MD, Robert P. Hasserjian, MD, Abner Louissaint, Jr., MD PhD, Meagan Montesion, PhD, Ethan S. Sokol, PhD, Dean C. Pavlick, Nikunj Shah, Natalie Danziger, Jonathan Keith Killian, MD,PhD, Eric A. Severson, MD, PhD, MMSc, Daniel Duncan, MD, Julia A. Elvin, MD, PhD, Vincent A. Miller, MD, Jeffrey S. Ross, MD, Jo-Anne Vergilio, MD, Lawrence R. Zukerberg, MD, Erik A. Williams, MD

Blood (2019) 134 (Supplement_1): 2541.

https://doi.org/10.1182/blood-2019-123729

Published: 2019

Journal Articles

Next Generation Sequencing of Castleman Disease and Follicular Dendritic Cell Sarcomas Associated with Castleman Disease

Alexandra Nagy, MD, Aparna Bhaduri, Nahid Shahmarvand, MD, Jahanbanoo Shahryari, MD, James L. Zehnder, MD, Roger Warnke, MD, Tariq I Mughal, MD FRCP, Siraj M Ali, MD PhD, Robert S. Ohgami, MD PhD

Blood (2017) 130 (Supplement 1): 4016.

https://doi.org/10.1182/blood.V130.Suppl_1.4016.4016

Published: 2017

Journal Articles

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

Preetesh Jain, MBBS,MDDM,PhD, Keyur P. Patel, MD PhD, Andrew Futreal, PhD, Curtis Gumbs, Shimin Hu, PhD MD, Carlos Bueso Ramos, MD, Michael Wang, MD, Jorge Romaguera, Luis E. Fayad, MD, Robert Z. Orlowski, PhD, MD, Jeffrey Medeiros, Nathan Fowler, MD

Blood (2015) 126 (23): 2700.

https://doi.org/10.1182/blood.V126.23.2700.2700

Published: 2015

Journal Articles

Human Immunodeficiency Virus-Negative Castleman's Disease: Clinicopathological and Laboratory Characteristics and Outcomes in Patients Treated in a Single Institution

Nalini Hasija, MD, Liliana Bustamante, MD, Michael V. Jaglal, MD, Lubomir Sokol, MD PhD

Blood (2015) 126 (23): 5027.

https://doi.org/10.1182/blood.V126.23.5027.5027

Published: 2015

Journal Articles

The Identification of Novel Therapies for the Treatment of Follicular Dendritic Cell Sarcoma

Bo Wang, MD, Liang Zhang, MD PhD, Lan Pham, PhD, Wenjing Tao, PhD, Hui Zhang, Jingmeng Xie, Wendy Chen, Qingqing Cai, MD PhD, Dehui Zou, MD PhD, Donglu Zhao, MD, Xiuhua Sun, MDPhD, Rong Liang, MD PhD, Jack Wang, Krystle Nomie, PhD, Nathan Fowler, MD, Michael Wang, MD

Blood (2015) 126 (23): 5126.

https://doi.org/10.1182/blood.V126.23.5126.5126

Published: 2015

Journal Articles

Immature T-Cell Populations in Lymph Nodes of Castleman Disease and Angioimmunoblastic T-Cell Lymphoma Suggest Alternate Sites of T-Cell Development,

Robert S. Ohgami, MD, PhD, Shuchun Chun, Jane Ohgami, JD, James L. Zehnder, MD, Matthew Van de Rijn, MD, PhD, Daniel A. Arber, MD, Yasodha Natkunam, MD, PhD, Roger Warnke, MD

Blood (2011) 118 (21): 3238.

https://doi.org/10.1182/blood.V118.21.3238.3238

Published: 2011

Journal Articles

EBV-Associated Follicular Dendritic Cell Tumor of the Spleen.

M. Houman Fekrazad, MD, Lizabeth Rosenbaum, M.D., Mohammad A. Vasef, M.D., Ian Rabinowitz, M.D.

Blood (2007) 110 (11): 4509.

https://doi.org/10.1182/blood.V110.11.4509.4509

Published: 2007

Journal Articles

Novel Diagnostic Scheme for Follicular Dendritic Cell Neoplasm: Clinicopathologic Analysis of 146 Cases.

Tae-Jung Kim, Yeonsook Moon, Kyungji Lee, Gyeongsin Park, Youn-Soo Lee, Chang-Suk Kang, Sang-In Shim, Kyo-Young Lee

Blood (2006) 108 (11): 2385.

https://doi.org/10.1182/blood.V108.11.2385.2385

Published: 2006

Journal Articles

Follicular Dendritic Cell Sarcoma (FDCS): A Rare and Incurable Disease.

Andres O. Soriano, MD, Michael Thompson, MD, Jorge Romaguera, MD, Alma Rodriguez, MD, Fredrick B. Hagemeister, MD, Luis Fayad, MD, Joan H. Admirand, MD, Barbara Pro, MD

Blood (2005) 106 (11): 3892.

https://doi.org/10.1182/blood.V106.11.3892.3892

Published: 2005

NARROW

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Next Generation Sequencing of Castleman Disease and Follicular Dendritic Cell Sarcomas Associated with Castleman Disease

Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS)

Human Immunodeficiency Virus-Negative Castleman's Disease: Clinicopathological and Laboratory Characteristics and Outcomes in Patients Treated in a Single Institution

The Identification of Novel Therapies for the Treatment of Follicular Dendritic Cell Sarcoma

Immature T-Cell Populations in Lymph Nodes of Castleman Disease and Angioimmunoblastic T-Cell Lymphoma Suggest Alternate Sites of T-Cell Development,

EBV-Associated Follicular Dendritic Cell Tumor of the Spleen.

Novel Diagnostic Scheme for Follicular Dendritic Cell Neoplasm: Clinicopathologic Analysis of 146 Cases.

Follicular Dendritic Cell Sarcoma (FDCS): A Rare and Incurable Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only